Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lymphoma,2008,NIAID,1K22AI070317-01A1,,Essential role of transcription factor Foxp1 in B cell development and function,"HU, HUI",WISTAR INSTITUTE,PA,"$162,000"
Lymphoma,2008,NCI,4R37CA054281-16,,Multiethnic Cohort Study of Diet and Cancer,"KOLONEL, LAURENCE",UNIVERSITY OF HAWAII AT MANOA,HI,"$2,292,128"
Lymphoma,2008,NCI,4R37CA042245-23,,Regulation of replication and latency EBV EBNAs,"HAYWARD, S",JOHNS HOPKINS UNIVERSITY,MD,"$367,373"
Lymphoma,2008,NCI,5F31CA126523-02,,Contributions of Epstein-Barr Virus EBNA2 and EBNA-LP to B cell immortalization,"ECHENDU, CHISAROKA",BAYLOR COLLEGE OF MEDICINE,TX,"$35,140"
Lymphoma,2008,NIAID,5R01AI058057-05,,Function of the gammaHV68 M2 Antigen,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$353,697"
Lymphoma,2008,NIEHS,5F32ES014777-02,,Role of estrogen receptor beta in cancer prevention by dietary indole-3-carbinol,"BENNINGHOFF, ABBY",OREGON STATE UNIVERSITY,OR,"$24,398"
Lymphoma,2008,NIAID,5R01AI057947-05,,IKK Signals in Lymphocyte Physiology and Pathology,"RAJEWSKY, KLAUS","IMMUNE DISEASE INSTITUTE, INC.",MA,"$439,502"
Lymphoma,2008,NIGMS,5R37GM032741-26,,INTRACHROMOSOMAL RECOMBINATION IN MAMMALIAN CELLS,"LISKAY, R",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$354,186"
Lymphoma,2008,NCI,5R01CA100925-04,,Role of P80 pro-IL-16 in T Cell Malignancy,"ZHANG, YUJUN",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$282,526"
Lymphoma,2008,NCI,5R01CA116093-02,,Effects of human SWI/SNF-associated PRMT5 on lymphomagenesis,"SIF, SAID",OHIO STATE UNIVERSITY,OH,"$256,500"
Lymphoma,2008,NCI,5R01CA124621-02,,Role of Arsenic Trioxide in Primary Effusion Lymphoma,"CHAUDHARY, PREET",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$278,353"
Lymphoma,2008,NIAID,1R13AI075650-01,,Keystone Symposium on Lymphocyte Activation and Signaling,"ROBERTSON, ANDREW",KEYSTONE SYMPOSIA,CO,"$10,000"
Lymphoma,2008,NCI,5R01CA100266-03,,Tumor Suppressors in Lymphocytes,"WABL, MATTHIAS",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$265,854"
Lymphoma,2008,NCI,5R01CA106662-04,,Dendritic Cell Threapy for Cutaneous T-Cell Lymphoma,"FALO, LOUIS",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$288,651"
Lymphoma,2008,NCI,5R01CA036327-25,,N-Ras Signaling in Tumorigenesis and Physiology,"PELLICER, ANGEL",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$458,935"
Lymphoma,2008,NIAID,5R01AI063058-04,,Roles of the Artemis nuclease in DNA repair and disease,"SEKIGUCHI, JOANN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$279,700"
Lymphoma,2008,NIAID,5R01AI063345-03,,Trophic Regulation in T Cell Homeostasis and Disease,"RATHMELL, JEFFREY",DUKE UNIVERSITY,NC,"$371,495"
Lymphoma,2008,NIDCR,5R01DE016669-04,,EBV Entry and Spread in the Oral Cavity,"HUTT-FLETCHER, LINDSEY",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$339,934"
Lymphoma,2008,NIAID,5R01AI061017-04,,Epstein-Barr virus glycoproteins and virus spread,"HUTT-FLETCHER, LINDSEY",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$303,468"
Lymphoma,2008,NCI,5R01CA078384-10,,E2A AS A POTENTIAL TUMOR SUPPRESSOR,"MURRE, CORNELIS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$384,245"
Lymphoma,2008,NCI,5R01CA107469-04,,Role of EZH2 in Breast Cancer,"KLEER, CELINA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$257,343"
Lymphoma,2008,NCI,5R01CA104348-05,,Transcriptional silencing by the Bcl-6 oncoprotein,"MELNICK, ARI",YESHIVA UNIVERSITY,NY,"$259,688"
Lymphoma,2008,NCI,5U01CA062406-14,,NABTT-New Approaches to Brain Tumor Therapy (CNSC),"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$57,838"
Lymphoma,2008,NCI,5R01CA084069-09,,Mechanisms of Cell Cycle Associated Neoplasia,"CLURMAN, BRUCE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$348,574"
Lymphoma,2008,NCI,5R01CA080320-10,,MYC Dependent Pathways in Apoptosis and Lymphomagenesis,"COLE, MICHAEL",DARTMOUTH COLLEGE,NH,"$341,132"
Lymphoma,2008,NCI,5R01CA058554-14,,Molecular genetics of Mouse Lung Tumors,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$248,200"
Lymphoma,2008,NCI,5R01CA072649-11,,Somatic Mutation of Ig Variable Regions,"SCHARFF, MATTHEW",YESHIVA UNIVERSITY,NY,"$397,545"
Lymphoma,2008,NCI,5R01CA058853-15,,Regulation of EBV Infection in Epithelial Cells,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$278,599"
Lymphoma,2008,NCI,1R01CA130826-01,,Software & Hardware Inference Engines for Automated Determination of Primary Cell,"NOLAN, GARRY",STANFORD UNIVERSITY,CA,"$1,671,372"
Lymphoma,2008,NCI,5F32CA123777-03,,Understanding the Role of Autophagy in Cancer,"DORSEY, FRANK",SCRIPPS RESEARCH INSTITUTE,CA,"$51,278"
Lymphoma,2008,NCI,5R01CA095431-04,,Regulation of the Tp12 Kinase,"TSICHLIS, PHILIP",TUFTS  MEDICAL CENTER,MA,"$274,719"
Lymphoma,2008,NCI,5R01CA125658-02,,Rac GTPases as Targets in Lymphomagenesis,"ZHENG, YI",CHILDREN'S HOSPITAL MED CTR (CINCINNATI),OH,"$285,000"
Lymphoma,2008,NCI,5R01CA030356-27,,EBV Genome Expression:Localization of Specific Functions,"HAYWARD, S",JOHNS HOPKINS UNIVERSITY,MD,"$330,440"
Lymphoma,2008,NCI,5R01CA113872-04,,Role of OCA-B in B cell differentiation and malignancy,"ROEDER, ROBERT",ROCKEFELLER UNIVERSITY,NY,"$522,190"
Lymphoma,2008,NIAID,1R21AI076720-01,,Wnt/b-catenin signaling in T-cell transformation,"GOUNARI, FOTINI",UNIVERSITY OF CHICAGO,IL,"$191,875"
Lymphoma,2008,NCI,5R01CA100875-05,,Mechanisms of T Cell Tumorigenesis,"CHEN, JIANZHU",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$238,942"
Lymphoma,2008,NCI,5R01CA091791-07,,Reactivation of Kaposi's sarcoma-associated herpesvirus,"SUN, REN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$281,463"
Lymphoma,2008,NHLBI,1K08HL091517-01,,Annexin 2 in Lymphoproliferative Angiogenesis,"RUAN, JIA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$131,490"
Lymphoma,2008,NCI,5R01CA100555-04,,Lymphoma Defined Cytogenetically for Epidemiologic Study,"CHIU, BRIAN",NORTHWESTERN UNIVERSITY,IL,"$202,456"
Lymphoma,2008,NCI,5R01CA121180-03,,A Comprehensive Investigation of Viral-induced Lymphomagenesis,"FISHER, SUSAN",UNIVERSITY OF ROCHESTER,NY,"$267,494"
Lymphoma,2008,NIAID,1R21AI076747-01,,Exploring the Mechanisms of 53BP1-driven Immune Deficiency and DNA Repair,"CARPENTER, PHILLIP",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$223,685"
Lymphoma,2008,NCI,5R01CA065883-14,,Epstein Barr Virus Latency,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$304,330"
Lymphoma,2008,NCI,1K99CA131474-01,,Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells,"NEILSON, JOEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$94,499"
Lymphoma,2008,NCI,5R01CA104588-05,,RAG-induced DNA damage: mechanisms and responses,"ROTH, DAVID",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$290,532"
Lymphoma,2008,NCI,5R01CA109518-04,,Cellular Targets for Gallium Compounds in Lymphoma,"CHITAMBAR, CHRISTOPHER",MEDICAL COLLEGE OF WISCONSIN,WI,"$255,337"
Lymphoma,2008,NCI,5R01CA105043-05,,Pathogenesis & Therapy of 8p11 Leukemia/Lymphoma,"VAN ETTEN, RICHARD",TUFTS  MEDICAL CENTER,MA,"$316,836"
Lymphoma,2008,NCI,5R01CA100053-04,,Cell Autonomy and Tumor Suppression by CDK inhibitors,"FERO, MATTHEW",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$340,846"
Lymphoma,2008,NCI,5U10CA013612-35,,SOUTHWEST ONCOLOGY GROUP,"MILLER, THOMAS",UNIVERSITY OF ARIZONA,AZ,"$266,506"
Lymphoma,2008,NHLBI,1R15HL091511-01,,Gfi-1 in the regulation of p21Cip,"DONG, FAN",UNIVERSITY OF TOLEDO,OH,"$216,000"
Lymphoma,2008,NCI,2R01CA092104-05A2,,Biologic Therapy for B-cell non-Hodgkin's Lymphoma,"ANSELL, STEPHEN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$258,741"
Lymphoma,2008,NCI,5R01CA109474-03,,Doxorubicin-Immunoconjugate Therapy of Non-Hodgkin's Lymphoma,"STEIN, RHONA",CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY,NJ,"$255,220"
Lymphoma,2008,NIAID,5R01AI064345-04,,Role of RNA silencing in B cell development and function,"RAJEWSKY, KLAUS","IMMUNE DISEASE INSTITUTE, INC.",MA,"$567,883"
Lymphoma,2008,NCI,5R01CA107300-05,,A NOVEL MECHANISM OF TCL1 TUMORIGENESIS,"TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$270,281"
Lymphoma,2008,NCI,7R01CA102142-05,,Role of POZ-zinc finger proteins in hemopoietic malignacies,"PANDOLFI, PIER PAOLO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$330,443"
Lymphoma,2008,NIGMS,5R01GM048026-16,,V(D)J Recombination Activating Genes-Functional Analysis,"OETTINGER, MARJORIE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$399,324"
Lymphoma,2008,NCI,5R01CA117827-04,,Function of the Epstein-Barr Virus EBNA-A3 Protein,"SAMPLE, CLARE",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$251,251"
Lymphoma,2008,NCI,1R01CA122569-01A2,,Toll Receptor Ligand Therapy of Cutaneous T-Cell Lymphoma,"ROOK, ALAIN",UNIVERSITY OF PENNSYLVANIA,PA,"$283,500"
Lymphoma,2008,NIAID,1R01AI068907-01A2,,"Transcriptional Control of Th-POK, a Key Regulator of Lineage Control","KAPPES, DIETMAR",INSTITUTE FOR CANCER RESEARCH,PA,"$472,923"
Lymphoma,2008,NCI,2R01CA076287-10,,Pretargeted Radioimmunotherapy of CD20+ Lymphomas,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$380,807"
Lymphoma,2008,NCI,5R01CA108951-04,,Oncogenic properties of interferon regulatory factor 7,"ZHANG, LUWEN",UNIVERSITY OF NEBRASKA LINCOLN,NE,"$217,299"
Lymphoma,2008,NCI,5R01CA119066-03,,Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2,"LOOK, A",DANA-FARBER CANCER INSTITUTE,MA,"$303,525"
Lymphoma,2008,NIAID,5R01AI060729-03,,Stage-specific Signaling in Peripheral B Cell Selection,"KHAN, WASIF",VANDERBILT UNIVERSITY,TN,"$365,542"
Lymphoma,2008,NCI,1R01CA124540-01A1,,Multiple Roles of the API2 Moiety in API2-MALT1-Mediated Lymphomagenesis,"MCALLISTER-LUCAS, LINDA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$319,230"
Lymphoma,2008,NCI,5R01CA056645-16,,FUNCTION OF EBV EBNA-3C IN B CELL IMMORTALIZATION,"SAMPLE, CLARE",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$230,935"
Lymphoma,2008,NCI,5R01CA077553-09,,Mechanism of T cell lymphoma in E protein deficiency,"SUN, XIAO-HONG",OKLAHOMA MEDICAL RESEARCH FOUNDATION,OK,"$285,911"
Lymphoma,2008,NIAID,2R01AI018757-26,,Host Immunity to EBV Infection in Vitro and in VIvo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$410,729"
Lymphoma,2008,NCI,1R01CA122539-01A2,,Lymphoproliferative Disorders in Primary Immunodeficiencies,"ROUTES, JOHN",MEDICAL COLLEGE OF WISCONSIN,WI,"$314,363"
Lymphoma,2008,NCI,1R01CA122645-01A1,,Rituximab Elicitation of Tumor Specific T-cell Responses in Lymphoma Patients,"BERNSTEIN, STEVEN",UNIVERSITY OF ROCHESTER,NY,"$329,408"
Lymphoma,2008,NCI,2R01CA031534-24,,MAR Mediated Control of The IgH Enhancer,"TUCKER, PHILIP",UNIVERSITY OF TEXAS AUSTIN,TX,"$257,359"
Lymphoma,2008,NCI,5R21CA126463-02,,EBV Pathogenesis in a New Mouse Model,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$146,735"
Lymphoma,2008,NCI,5R01CA124332-02,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$277,400"
Lymphoma,2008,NCI,5R21CA121569-02,,BLys inhibition using TACI-Fc in patients with B-bell non-Hodgkins' Lymphoma,"ANSELL, STEPHEN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$281,200"
Lymphoma,2008,NCI,5U10CA046282-21,,Southwest Oncology Group,"STIFF, PATRICK",LOYOLA UNIVERSITY CHICAGO,IL,"$382,959"
Lymphoma,2008,NCI,2P01CA100730-06,0006,Role of Bone Microenvironment in Tax Induced Malignancies,"WEILBAECHER, KATHERINE",WASHINGTON UNIVERSITY,MO,"$260,361"
Lymphoma,2008,NCI,2P01CA100730-06,0005,Role of Inflammation in Tax-mediated Tumorigenesis,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$298,986"
Lymphoma,2008,NCI,4R37CA012055-36,,Studies of Epstein-Barr Virus,"MILLER, I.",YALE UNIVERSITY,CT,"$451,285"
Lymphoma,2008,NCI,5R01CA090233-07,,Lineage Commitment Mechanisms in Lymphoid Precursors,"ROTHENBERG, ELLEN",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$363,528"
Lymphoma,2008,NCI,5R01CA120185-02,,c-Myc-regulated microRNAs in normal and pathologic cellular physiology,"MENDELL, JOSHUA",JOHNS HOPKINS UNIVERSITY,MD,"$309,168"
Lymphoma,2008,NCI,2R01CA083937-06A2,,Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis,"GELINAS, CELINE",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$247,822"
Lymphoma,2008,NIDDK,5R01DK047636-13,,Hematopoietic specific Genes in Stem Cell Development,"LIM, BING",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$334,101"
Lymphoma,2008,NIAID,1R21AI073627-01A1,,Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine,"SNAPPER, CLIFFORD",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$192,375"
Lymphoma,2008,NCI,5R01CA085573-08,,Role of the BCL 6 Proto Oncogene in B Cell Lymphomas,"YE, BIHUI",YESHIVA UNIVERSITY,NY,"$347,533"
Lymphoma,2008,NCI,5R01CA070723-12,,Genetic Analysis of EBV's Immortalizing Genes,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$293,829"
Lymphoma,2008,NCI,5R01CA103646-05,,KSHV vFLIP in B cell survival,"CESARMAN, ETHEL",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$326,554"
Lymphoma,2008,NCI,5R01CA103642-05,,Immune surveillance in murine gammaherpesvirus infection,"USHERWOOD, EDWARD",DARTMOUTH COLLEGE,NH,"$279,728"
Lymphoma,2008,NCI,5R01CA033192-21,,Transformation by Reticuloendotheliosis Virus,"BOSE, HENRY",UNIVERSITY OF TEXAS AUSTIN,TX,"$302,573"
Lymphoma,2008,NCRR,1S10RR024749-01,,Console for a 4.7 T small animal MRI system,"PICKUP, STEPHEN",UNIVERSITY OF PENNSYLVANIA,PA,"$499,858"
Lymphoma,2008,NIAMS,5K23AR051125-05,,Investigating the Risk of Lymphoma in Psoriasis Patients,"GELFAND, JOEL",UNIVERSITY OF PENNSYLVANIA,PA,"$132,462"
Lymphoma,2008,NCI,5R01CA093237-07,,Nuclear Accumulation of Cyclin D1 and Oncogenesis,"DIEHL, J",UNIVERSITY OF PENNSYLVANIA,PA,"$294,539"
Lymphoma,2008,NCI,5R21CA126060-02,,CD 74 Directed Immunotherapy for B Cell Malignancies,"LEONARD, JOHN",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$327,262"
Lymphoma,2008,NCI,1R43CA132390-01,,Therapeutic Cancer Vaccine for Non-Hodgkin's Lymphoma,"ROBB, RICHARD","XEME BIOPHARMA, INC",NJ,"$167,401"
Lymphoma,2008,NCI,5R01CA117935-02,,p53-Independent Pathways in Mdm2-Mediated Transformation,"EISCHEN, CHRISTINE",VANDERBILT UNIVERSITY,TN,"$291,850"
Lymphoma,2008,NCI,5R01CA106550-04,,The Tumor Suppression Potential of NF-kappaB2 p100,"DING, HAN-FEI",UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS,OH,"$1,949"
Lymphoma,2008,NCI,5K23CA123149-02,,Antigen Discovery and Development of Tumor-Specific Lymphoma Immunotherapy,"NEELAPU, SATTVA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$136,080"
Lymphoma,2008,NCI,5U10CA073590-12,,SWOG Institutional Grant,"SONDAK, VERNON",H. LEE MOFFITT CANCER CTR & RES INST,FL,$1
Lymphoma,2008,NINR,1R43NR010441-01A1,,Telenursing Model for Management of Chemotherapy Side Effects,"YANG, DERSHUNG","CARACAL, INC.",IL,"$99,767"
Lymphoma,2008,NCI,7R01CA106156-05,,Cell growth deregulation by KSHV protein,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$285,151"
Lymphoma,2008,NCI,1F32CA132307-01,,Phosphorylation sites that regulate c-Myc's proliferative and apoptotic functions,"BYERS, SARAH",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$49,646"
Lymphoma,2008,NCI,1F32CA132350-01,,Coordinate Suppression of B Cell Lymphoma by PTEN and SHIP,"MILETIC SEDY, ANA",BURNHAM INSTITUTE FOR MEDICAL RESEARCH,CA,"$49,646"
Lymphoma,2008,NCI,5R01CA114504-04,,PRDI-BF1 and histone methyltransferase in lymphoma,"WRIGHT, KENNETH",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$230,795"
Lymphoma,2008,NCI,5R01CA068328-12,,c-Myc Expression during Lymphomagenesis,"RUDDELL, M",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$337,199"
Lymphoma,2008,NCI,2P01CA094237-06,0001,OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$268,054"
Lymphoma,2008,NCI,2P01CA094237-06,0002,THE ROLE AND MECHANISMS OF CD4+ T CELLS IN ANTITUMOR IMMUNITY,"WANG, RONGFU",BAYLOR COLLEGE OF MEDICINE,TX,"$268,054"
Lymphoma,2008,NCI,5R01CA075922-12,,Rhesus HHV-8 homologue in AIDS-related malignancies,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$595,989"
Lymphoma,2008,NCI,5R01CA111807-04,,The Role of Toll-Like Receptors in Cancer Immunotherapy,"YANG, YIPING",DUKE UNIVERSITY,NC,"$288,390"
Lymphoma,2008,NCI,5R01CA116933-02,,Preventing Tumorigenesis in Developing Lymphocytes,"ZHU, CHENGMING",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$292,600"
Lymphoma,2008,NCI,1P50CA121973-01A1,0005,Augmentation of Dendritic Cell-based Immunotherapy for Sezary Syndrome by T-reg D,"FALO, LOUIS",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$124,792"
Lymphoma,2008,NCI,5R01CA118559-02,,IN VIVO 31P MRS STUDIES OF NON-HODGKIN'S LYMPHOMA,"BROWN, TRUMAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$1,174,250"
Lymphoma,2008,NIDDK,5K01DK074555-03,,Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2,"JETTE, CICELY",DANA-FARBER CANCER INSTITUTE,MA,"$134,110"
Lymphoma,2008,NCI,5R01CA105157-05,,Pathways of Death and Survival in EBV B Cell Lymphomas,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$248,803"
Lymphoma,2008,NCI,5K22CA113493-02,,Role of MAP kinases in anaplastic large cell lymphoma,"ZU, YOULI",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$151,200"
Lymphoma,2008,NCI,7R01CA104596-04,,Expression and Function of Tob in T Lymphocytes,"BOUSSIOTIS, VASSILIKI",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$318,352"
Lymphoma,2008,NCI,5R03CA125831-02,,Occupational risk factors for NHL and NHL subtypes: an InterLymph-based analysis,"MANNETJE, ANDREA",MASSEY UNIVERSITY,NEW ZE,"$55,123"
Lymphoma,2008,NCI,5R01CA113794-04,,"The function of Snf5, an epigenetic tumor suppressor","ROBERTS, CHARLES",DANA-FARBER CANCER INSTITUTE,MA,"$320,225"
Lymphoma,2008,NCI,5R01CA124311-02,,"Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$254,790"
Lymphoma,2008,NCI,5R01CA085888-09,,Malignant Complications of Chronic HCV,"LOFFREDO, CHRISTOPHER",GEORGETOWN UNIVERSITY,DC,"$297,351"
Lymphoma,2008,NCI,5R21CA119918-02,,Antiangiogenic Therapy for AIDS-Associated Lymphomas,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$157,000"
Lymphoma,2008,NCI,5R01CA058524-14,,Regulation of EBV Transcription in Burkitt's Lymphoma,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$272,412"
Lymphoma,2008,NCI,5R01CA114416-03,,Epstein-Barr Virus-Enhanced Tumor Progression,"SIXBEY, JOHN",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$283,896"
Lymphoma,2008,NCI,5R01CA081133-10,,Post-transcriptional Gene Regulation by EBV SM Protein,"SWAMINATHAN, SANKAR",UNIVERSITY OF FLORIDA,FL,"$248,329"
Lymphoma,2008,NCI,5R01CA113518-03,,Tetravalent antibodies with altered FcRn binding sites,"SMALLSHAW, JOAN",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$173,790"
Lymphoma,2008,NIA,5R01AG026661-03,,Role of RecQ Helicases to Prevent Senescence By c-Myc,"GRANDORI, CARLA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$303,731"
Lymphoma,2008,NCI,5R01CA089305-07,,MYC's Role in the Initiation and Maintenance of Cancer,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$379,965"
Lymphoma,2008,NCI,5R01CA102667-04,,Effects of Malaria on EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$261,947"
Lymphoma,2008,NCI,7R01CA109697-04,,Herpesvirus saimiri TIP,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$274,719"
Lymphoma,2008,NCI,5R01CA117802-03,,MYC-induced breach of B-cell anergy in AIDS-related NHLs,"REFAELI, YOSEF",NATIONAL JEWISH HEALTH,CO,"$241,983"
Lymphoma,2008,NCI,5R01CA092229-08,,Helicobacter Host Interactions in Animal Models,"FALKOW, STANLEY",STANFORD UNIVERSITY,CA,"$283,219"
Lymphoma,2008,NCI,5R01CA104818-05,,SV40 Pathogenesis of Human Infections,"BUTEL, JANET",BAYLOR COLLEGE OF MEDICINE,TX,"$467,229"
Lymphoma,2008,NCI,5R01CA071768-12,,Redox Control of Apoptosis Signaling,"BRIEHL, MARGARET",UNIVERSITY OF ARIZONA,AZ,"$221,264"
Lymphoma,2008,NCI,5R01CA107489-05,,Role of BCL6 Mutation in Lymphomagenesis,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$317,808"
Lymphoma,2008,NCI,5R01CA101795-05,,Novel Strategies for Immunotherapy of Cancer,"WANG, RONGFU",BAYLOR COLLEGE OF MEDICINE,TX,"$263,284"
Lymphoma,2008,NCI,5R03CA128052-02,,Lymphoma in Autoimmune Disease: Consequence of Immune Suppression or Stimulation?,"BERNATSKY, SASHA",MCGILL UNIVERSITY HEALTH CTR RES INST,CANADA,"$54,000"
Lymphoma,2008,NCI,5K23CA113775-03,,Proteosome Inhibition Therapy for Hematologic Malignancy,"HORTON, TERZAH",BAYLOR COLLEGE OF MEDICINE,TX,"$134,015"
Lymphoma,2008,NCI,5R01CA106705-04,,Cyclic AMP-mediated apoptosis in lymphoid malignancies,"LERNER, ADAM",BOSTON MEDICAL CENTER,MA,"$241,199"
Lymphoma,2008,NHLBI,5R21HL085189-02,,Role of vFLIP K13 in Bone Marrow Failure Syndrome Associated with Infection by Hu,"CHAUDHARY, PREET",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$222,750"
Lymphoma,2008,NCI,5R01CA109232-05,,Regulation of the KSHV latent promoter,"DITTMER, DIRK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$225,602"
Lymphoma,2008,NCI,5R01CA071796-11,,Multistep Lymphomagenesis/Tumorigenesis in Transgenic Mice: Protein Kinase Ck2,"SELDIN, DAVID",BOSTON MEDICAL CENTER,MA,"$275,767"
Lymphoma,2008,NIDCR,5R01DE018304-02,,ART Modulation of Viral Pathogenesis in Oral Epithelia,"DITTMER, DIRK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$317,667"
Lymphoma,2008,NCI,5R01CA047763-21,,Transformation of Cells by the REL Oncogene,"GILMORE, THOMAS",BOSTON UNIVERSITY,MA,"$275,637"
Lymphoma,2008,NCI,5R01CA102646-04,,USE OF mTOR INHIBITORS IN B CELL LEUKEMIA,"GRUPP, STEPHAN",CHILDREN'S HOSPITAL OF PHILADELPHIA,PA,"$311,617"
Lymphoma,2008,NCI,5R21CA126119-02,,Regulation of the P13K/AKT pathway in Waldenstrom Macroglobulinemia,"GHOBRIAL, IRENE",DANA-FARBER CANCER INSTITUTE,MA,"$321,536"
Lymphoma,2008,NIGMS,5F32GM076816-02,,Organocatalytic Asymmetric Cascade Reactions,"NICEWICZ, DAVID",PRINCETON UNIVERSITY,NJ,"$46,826"
Lymphoma,2008,NCI,5U10CA016116-35,,Eastern Cooperative Oncology Group,"FORASTIERE, ARLENE",JOHNS HOPKINS UNIVERSITY,MD,"$279,595"
Lymphoma,2008,NCI,5R01CA068051-13,,Pathogenesis of Epstein-Barr Virus Infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$407,881"
Lymphoma,2008,NCI,5K08CA105064-05,,A Pull-Push Strategy for Lymphoma Immunotherapy,"SONG, WENRU",BAYLOR RESEARCH INSTITUTE,TX,"$128,547"
Lymphoma,2008,NCI,5U10CA021076-33,,EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES,"KAHL, BRAD",UNIVERSITY OF WISCONSIN MADISON,WI,"$610,603"
Lymphoma,2008,NCI,5R01CA095043-05,,Activation of the LMP-1 Protein of Epstein-Barr Virus,"MARTIN, JENNIFER",UNIVERSITY OF COLORADO AT BOULDER,CO,"$231,698"
Lymphoma,2008,NCI,5R01CA085177-09,,"Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig","CHAUDHARY, PREET",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$236,554"
Lymphoma,2008,NIAID,5R01AI076972-02,,Programming of CD8+ T Cell Tolerance by B Cell APC,"SCHOENBERGER, STEPHEN",LA JOLLA INST FOR ALLERGY & IMMUNOLGY,CA,"$460,020"
Lymphoma,2008,NCI,5R01CA105001-05,,MS4A Family Members in Health and Disease,"TEDDER, THOMAS",DUKE UNIVERSITY,NC,"$239,473"
Lymphoma,2008,NCI,5R01CA063417-10,,Proliferative Effects of HTLV-1,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$317,369"
Lymphoma,2008,FIC,1R03TW007821-01A1,,Micronutrient Malnutrition and EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$39,031"
Lymphoma,2008,NIAID,5R13AI066870-04,,"Lymphocytes and the Immune System Molecular, Cellular and Interactive Mechanisms","ROTHENBERG, ELLEN",FEDERATION OF AMER SOC FOR EXPER BIOLOGY,MD,$1
Lymphoma,2008,NCI,5R01CA127238-02,,Herpesvirus-induced telomerase dysregulation and tumor formation,"OSTERRIEDER, NIKOLAUS",CORNELL UNIVERSITY ITHACA,NY,"$228,723"
Lymphoma,2008,NCI,5R01CA106159-04,,Role of Epstein-Barr virus LMP1 in lymphoma,"IZUMI, KENNETH",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$218,727"
Lymphoma,2008,NCI,5R01CA113579-04,,Role and therapeutical potential of Cdk4/6 in B-lymphoma,"ZOU, XIANGHONG",OHIO STATE UNIVERSITY,OH,"$193,715"
Lymphoma,2008,NCI,5R03CA128006-02,,Proteomic biomarkers for lymphoma,"DENIS, GERALD",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$81,250"
Lymphoma,2008,NCI,5K01CA106596-05,,BAD Intergrates Glycolysis and Apoptosis,"DANIAL, NIKA",DANA-FARBER CANCER INSTITUTE,MA,"$158,490"
Lymphoma,2008,NICHD,5R01HD037091-11,,Regulation of B Cell Development and Signaling by Btk,"RAWLINGS, DAVID",CHILDREN'S HOSPITAL AND REG MEDICAL CTR,WA,"$324,065"
Lymphoma,2008,NCI,1R01CA133046-01,,Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents,"CANMAN, CHRISTINE",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$283,860"
Lymphoma,2008,NCI,5R01CA068682-18,,Biomedical Applications of Expanded Porphyrins,"SESSLER, JONATHAN",UNIVERSITY OF TEXAS AUSTIN,TX,"$305,354"
Lymphoma,2008,NIBIB,5R21EB006483-02,,Analysis of Kaposi's sarcoma-associated herpesvirus infection using Raman tweezer,"AKULA, SHAW",EAST CAROLINA UNIVERSITY,NC,"$139,650"
Lymphoma,2008,NCI,1R01CA133027-01,,"EBV's Plasmid Replicon: Its Synthesis, Partitioning, and Maintenance of Tumors","SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$300,378"
Lymphoma,2008,NCI,5R01CA111185-05,,K-bZIP and Transcriptional Regulation of KSHV,"KUNG, HSING-JIEN",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$223,860"
Lymphoma,2008,NCI,5T32CA009140-34,,Immunobiology of normal and neoplastic lymphocytes,"PATERSON, YVONNE",UNIVERSITY OF PENNSYLVANIA,PA,"$647,893"
Lymphoma,2008,NIDDK,1K01DK080894-01,,DNA EXCHANGE DURING STOMACH COLONIZATION BY HELICOBACTER PYLORI,"DORER, MARION",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$98,264"
Lymphoma,2008,NIAID,5K08AI062732-04,,Early cellular immune responses to EBV,"BHADURI-MCINTOSH, SUMITA",YALE UNIVERSITY,CT,"$136,620"
Lymphoma,2008,NCI,5R01CA093729-07,,Repair of Genome Destabilizing DNA Structures,"VASQUEZ, KAREN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$307,161"
Lymphoma,2008,NCI,5K22CA120147-02,,Interaction of TCL1 with a novel exoribonuclease,"FRENCH, SAMUEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$152,820"
Lymphoma,2008,NCI,5R01CA121039-02,,B Cell Lymphoma Therapy,"CHOI, YONG",OCHSNER CLINIC FOUNDATION,LA,"$244,245"
Lymphoma,2008,NCI,5R01CA040041-23,,SURFACE ANTIGENS OF MURINE T LYMPHOMAS,"ALLISON, JAMES",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$311,649"
Lymphoma,2008,NCI,5R01CA042755-22,,Mechanism of Steroid Action in Lymphoid Malignancy,"DISTELHORST, CLARK",CASE WESTERN RESERVE UNIVERSITY,OH,"$311,299"
Lymphoma,2008,NCI,5R01CA113874-04,,Immunotherapy with Gamma Delta T Cells for B Cell Tumors,"MORITA, CRAIG",UNIVERSITY OF IOWA,IA,"$220,974"
Lymphoma,2008,NCI,5U10CA047642-21,,University of Iowa CALGB Institutional Grant,"VAENA, DANIEL",UNIVERSITY OF IOWA,IA,"$110,413"
Lymphoma,2008,NCI,2R01CA092153-06,,Molecular Epidemiology of NHL and CLL,"CERHAN, JAMES","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$629,749"
Lymphoma,2008,NCI,5K07CA108565-03,,QOL and Service Needs of Leukemia/Lymphoma Survivors,"PARRY, CARLA",UNIVERSITY OF COLORADO DENVER,CO,"$133,703"
Lymphoma,2008,NCI,5R21CA116127-02,,UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY,"COOPER, LAURENCE",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$168,750"
Lymphoma,2008,NCI,5R33CA112061-04,,Quantitative proteomic analysis of lymphoma transformation,"ELENITOBA-JOHNSON, KOJO",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$283,132"
Lymphoma,2008,NCI,5R01CA124309-03,,Role of PML nuclear body proteins for establishment of EBV latent infection,"LING, PAUL",BAYLOR COLLEGE OF MEDICINE,TX,"$258,530"
Lymphoma,2008,NCI,5K23CA115682-04,,Genetic Alterations in Families with Multiple Lymphomas,"BROWN, JENNIFER",DANA-FARBER CANCER INSTITUTE,MA,"$136,890"
Lymphoma,2008,NCI,5K23CA109613-04,,Targeting the Mitochondria to Treat Lymphoma and Myeloma,"EVENS, ANDREW",NORTHWESTERN UNIVERSITY,IL,"$131,450"
Lymphoma,2008,NCI,5R01CA125195-02,,Molecular Pathways in Suppression and Development of T Lineage Lymphomas,"BASSING, CRAIG",CHILDREN'S HOSPITAL OF PHILADELPHIA,PA,"$312,629"
Lymphoma,2008,NCI,5R01CA088768-09,,Structure and Molecular Composition of KSHV and RRV,"KEDES, DEAN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$476,141"
Lymphoma,2008,NCI,5R21CA129045-02,,Prognostic Genetic Biomarkers for Cancer,"ONEL, KENAN",UNIVERSITY OF CHICAGO,IL,"$122,800"
Lymphoma,2008,NCI,5R01CA083823-07,,Selective Forces Operative in FeLV Infection,"LEVY, LAURA",TULANE UNIVERSITY OF LOUISIANA,LA,"$268,515"
Lymphoma,2008,NCI,5R01CA121195-03,,Prediagnostic Markers of Immune Activation and Viral Infection and Risk of NHL,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$395,273"
Lymphoma,2008,NCI,1R01CA134051-01A2,,T Cell Immunity in Endemic Burkitt Lymphoma,"MOORMANN, ANN",CASE WESTERN RESERVE UNIVERSITY,OH,"$485,971"
Lymphoma,2008,NCI,2R01CA071540-11A2,,Molecular Basis of Action of the Putative Oncogene BCL-6,"BARDWELL, VIVIAN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$311,163"
Lymphoma,2008,NIAID,2R01AI041769-11A1,,Cellular Mechanisms of PTLD in Transplant Recipients,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$354,265"
Lymphoma,2008,NCI,5R01CA085180-08,,Epstein-Barr Virus LMP-1 Mediated Oncogenicity,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$726,878"
Lymphoma,2008,NCI,5R01CA113261-05,,Gamma/Delta T Cells Surveillance of B Lymphoma in AIDS,"PAUZA, C.",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$224,720"
Lymphoma,2008,NCI,1R01CA129132-01A1,,Development of cambinol analogues as antilymphoma agents,"BEDALOV, ANTONIO",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$365,200"
Lymphoma,2008,NCI,2P50CA093683-06A2,0008,Generation of a Therapeutic Antibody Directed Against CCR4 for Patients with,"MARASCO, WAYNE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$216,958"
Lymphoma,2008,NIAID,2R01AI076183-06A2,,Structural and Functional Studies of gp42 and HLA Class II in EBV Entry,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$430,471"
Lymphoma,2008,NIDCR,5R01DE011390-21,,Regulation of Immunity by Prostaglandins,"PHIPPS, RICHARD",UNIVERSITY OF ROCHESTER,NY,"$354,752"
Lymphoma,2008,NCI,1R01CA128941-01A1,,Regulatory T cells in B cell lymphoma,"LEVITSKY, HYAM",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Lymphoma,2008,NCI,2P01CA022443-31,0012,Plasmid Replicons of Human Tumor Viruses,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$232,726"
Lymphoma,2008,NCI,2P01CA022443-31,0013,Mechanisms of Reactivation of Epstein-Barr Virus from Latency to Lytic Replicatio,"MERTZ, JANET",UNIVERSITY OF WISCONSIN MADISON,WI,"$200,142"
Lymphoma,2008,NIBIB,2R01EB002991-05A1,,Biofunctional Polymers for Intracellular Drug Delivery,"STAYTON, PATRICK",UNIVERSITY OF WASHINGTON,WA,"$501,959"
Lymphoma,2008,NIBIB,5R01EB001994-09,,SPECT/CT Image-Based Dosimetry in Radionuclide Tharapy,"DEWARAJA, YUNI",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$340,393"
Lymphoma,2008,NCI,5R01CA085721-09,,Experimental Therapy of Cancer by Costimulated Immunity,"CHEN, LIEPING",JOHNS HOPKINS UNIVERSITY,MD,"$325,256"
Lymphoma,2008,NCI,5K08CA114395-03,,Role of Jak3 in Anaplastic Large Cell Lymphoma,"AMIN, HESHAM",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$136,080"
Lymphoma,2008,NCI,5R01CA115665-03,,Molecular Mechanisms of Lymphomagenesis,"MILLS, KEVIN",JACKSON LABORATORY,ME,"$289,553"
Lymphoma,2008,NIAID,5R01AI071928-03,,Regulation of Latent-Lytic Switch in EBV by ZEB,"MERTZ, JANET",UNIVERSITY OF WISCONSIN MADISON,WI,"$350,063"
Lymphoma,2008,NCI,1K23CA124465-01A2,,Novel Biologic Therapies for Hodgkin's Lymphoma,"KASAMON, YVETTE",JOHNS HOPKINS UNIVERSITY,MD,"$140,940"
Lymphoma,2008,NCI,5K23CA100291-05,,Molecular Classification and therapy of CNS Lymphomas,"RUBENSTEIN, JAMES",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$127,026"
Lymphoma,2008,NCI,5K99CA125994-02,,Combining Computational and Experimentation to Interrogate NF-kappaB Signaling,"COVERT, MARKUS",STANFORD UNIVERSITY,CA,"$137,457"
Lymphoma,2008,NIAID,1K99AI072956-01A1,,"Roles for TAK1 in T cell development, function and tumorigenesis","WAN, YISONG",YALE UNIVERSITY,CT,$1
Lymphoma,2008,NCI,5R01CA057152-14,,Immune Dysfunction and AIDS-associated B Cell Lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$279,804"
Lymphoma,2008,NCI,1K08CA127353-01A1,,Epigenetic Mechanisms of Lymphomagenesis.,"SHAKNOVICH, RITA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$138,672"
Lymphoma,2008,NCI,1K24CA128953-01A1,,Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,"ANTONIA, SCOTT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$161,259"
Lymphoma,2008,NCI,5R01CA113454-03,,Targeted Gene Therapy for Lymphoma,"SMITH, BRUCE",AUBURN UNIVERSITY AT AUBURN,AL,"$256,177"
Lymphoma,2008,NCI,5R01CA109524-03,,IL-7 and Lymphocyte Homeostasis: Life versus Death,"KHALED, ANNETTE",UNIVERSITY OF CENTRAL FLORIDA,FL,"$195,792"
Lymphoma,2008,NCI,5K08CA101934-06,,Notch-Mediated Apoptosis in Human B Cell Malignancies,"ZWEIDLER-MCKAY, PATRICK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$136,080"
Lymphoma,2008,NCI,5R01CA096500-07,,Role of KSHV K1 in viral pathogenesis,"DAMANIA, BLOSSOM",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$279,757"
Lymphoma,2008,NCI,5R01CA087978-09,,HSV Amplicon Activation of Innate and Adaptive Immunity,"ROSENBLATT, JOSEPH",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$326,561"
Lymphoma,2008,NHLBI,1R01HL088686-01A2,,Modeling B cell Lymphoma in the Mouse,"RICKERT, ROBERT",BURNHAM INSTITUTE FOR MEDICAL RESEARCH,CA,"$477,500"
Lymphoma,2008,NCI,5K08CA104882-05,,ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES,"BROWN, VALERIE",CHILDREN'S HOSPITAL OF PHILADELPHIA,PA,"$138,672"
Lymphoma,2008,NCI,5R37CA037295-25,,AIDS Associated Lymphoproliferative Disorders,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$432,500"
Lymphoma,2008,NCI,5R01CA108872-03,,Dysregulation of ubiquitination in MALT lymphomas,"YANG, XIAOLU",UNIVERSITY OF PENNSYLVANIA,PA,"$244,309"
Lymphoma,2008,NCI,5R01CA092660-08,,Lymphocyte Survival: Implications for lymphomagenesis,"THOMPSON, CRAIG",UNIVERSITY OF PENNSYLVANIA,PA,"$310,988"
Lymphoma,2008,NIEHS,5R01ES015707-02,,Comparative Mechanisms of Genomic Instability,"VASQUEZ, KAREN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$358,435"
Lymphoma,2008,NCI,5R21CA128501-02,,High affinity ligand to deliver nanoparticle drugs to lymphoid cancers,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$152,000"
Lymphoma,2008,NCI,5R01CA089194-08,,Jak/STAT signaling in human T-cell lymphomas,"WASIK, MARIUSZ",UNIVERSITY OF PENNSYLVANIA,PA,"$249,891"
Lymphoma,2008,NCI,1R43CA133979-01,,Profiling methylation of individual CpG sites,"JIANG, XIN","SIGNOSIS, INC.",CA,"$157,290"
Lymphoma,2008,NCI,5U01CA114778-04,,Molecular Signatures to Improve Diagnosis and Outcome Pr,"CHAN, WING",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$1,674,031"
Lymphoma,2008,NIDCR,5R01DE018926-02,,Pathogenesis of oral rhesus lymphocryptovirus infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$374,562"
Lymphoma,2008,NCI,5R01CA121935-03,,Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings,"HARRINGTON, WILLIAM",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$248,486"
Lymphoma,2008,NCI,5R01CA122663-03,,A Genome-Wide Association Study of Non-Hodgkin Lymphoma,"SKIBOLA, CHRISTINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$529,626"
Lymphoma,2008,NCI,5U10CA077440-11,,WUMC-Cancer and Leukemia Group B,"BARTLETT, NANCY",WASHINGTON UNIVERSITY,MO,"$334,932"
Lymphoma,2008,NCI,5K01CA097283-05,,SATB1-protein Interaction/function at the BcL2 mbr/MAR,"DURRIN, LINDA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$159,138"
Lymphoma,2008,NCI,1R43CA134046-01,,Multimodal Diagnostic and Therapeutic Nanoparticles for Non-Hodgkin's Lymphoma,"CARTIERA, MALGORZATA",CARIGENT THERAPEUTICS,CT,"$204,344"
Lymphoma,2008,NCRR,7R24RR023343-02,,Herpesvirus latency and reactivation in macaque models of human disease,"ROSE, TIMOTHY",CHILDREN'S HOSPITAL AND REG MEDICAL CTR,WA,"$588,518"
Lymphoma,2008,NCRR,5K01RR023965-02,,Developing New Mouse Models of ATL for Use in Trials of Targeted Therapies,"ZIMMERMAN, BEVIN",OHIO STATE UNIVERSITY,OH,"$126,900"
Lymphoma,2008,NCI,5K08CA118260-03,,CD20 DNA VACCINATION FOR B-CELL LYMPHOMA,"PALOMBA, MARIA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$134,622"
Lymphoma,2008,NCI,5K99CA129172-02,,The Role of Bcl2L12 in the Genesis of Malignant Glioma,"STEGH, ALEXANDER",DANA-FARBER CANCER INSTITUTE,MA,"$90,000"
Lymphoma,2008,NCI,5R01CA090571-07,,TCL1 Oncogene in B Lymphocyte Development and Neoplasia,"TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$266,199"
Lymphoma,2008,NCI,1F31CA134209-01,,microRNAs Dysregulated by HMG-I in Neoplastic Transformation,"SMAIL, SHAMAYRA",JOHNS HOPKINS UNIVERSITY,MD,"$35,202"
Lymphoma,2008,NCI,4R37CA057138-18,,MYC ONCOPROTEIN FUNCTION,"EISENMAN, ROBERT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$821,506"
Lymphoma,2008,NCI,2P01CA022443-31,0010,Inhibiting The Survival And Proliferation Of EBV-Associated Tumor Cells,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$233,184"
Lymphoma,2008,NCI,1P50CA128346-01A1,0004,Developmental Projects,"MATTREY, ROBERT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$120,000"
Lymphoma,2008,NCI,5K01CA122192-02,,Cooperation of PTEN and SHIP as tumor suppressors in B-Cells,"PEDERSEN, IRENE",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$108,558"
Lymphoma,2008,NCI,1R01CA130752-01A1,,Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$309,175"
Lymphoma,2008,NHLBI,5R01HL083050-04,,Abnormalities in gene expression in therapy-related MDS,"BHATIA, RAVI",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$552,720"
Lymphoma,2008,NCI,2R01CA073507-11A2,,In Vivo Model of Epstein-Barr Virus Latency,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$377,500"
Lymphoma,2008,NCI,5R01CA112217-03,,Targeting of EBV Latency in Burkitt's Lymphoma,"HARRINGTON, WILLIAM",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$236,524"
Lymphoma,2008,NHLBI,5R01HL064851-08,,New EBV Therapies for treating malignancies,"PAGANO, JOSEPH",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$346,086"
Lymphoma,2008,NCI,5R21CA125398-02,,The Kinomes of Non-Hodgkin Lymphoma,"KERR, WILLIAM",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$162,270"
Lymphoma,2008,NCI,2R01CA066519-14A1,,EBV-based Strategies for AIDS-related Malignancies,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$276,467"
Lymphoma,2008,NCI,1R01CA132638-01A1,,Anti-viral IL6 approach to mitigate KSHV-related disease,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$643,832"
Lymphoma,2008,NCI,1R01CA134234-01,,Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma,"CHAO, CHUN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$500,000"
Lymphoma,2008,NCI,5R01CA020068-31,,Molecular Mechanisms in Neoplasia,"NEIMAN, PAUL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$264,000"
Lymphoma,2008,NCI,2R01CA068939-11A2,,Survival Signals in AIDS Lymphomas,"CESARMAN, ETHEL",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$468,855"
Lymphoma,2008,NCI,5R13CA124293-03,,Annual Primary CNS Lymphoma Collaborative Group Meeting,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$5,000"
Lymphoma,2008,NIAID,5R21AI068749-02,,Normal and aberrant switch recombination to the murine alpha heavy chain gene,"DUNNICK, WESLEY",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$220,515"
Lymphoma,2008,NCI,5R01CA127433-02,,Signal transduction inhibitor therapy for Lymphoma,"WITZIG, THOMAS","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$330,462"
Lymphoma,2008,NCI,5K22CA128882-02,,Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis,"CAREY, GREGORY",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$167,400"
Lymphoma,2008,NCI,5R01CA122105-02,,Prognostic Models in Diffuse Large B-Cell Lymphoma,"LOSSOS, IZIDORE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$274,195"
Lymphoma,2008,NCI,5R01CA128803-02,,Identifying determinants of chemotherapeutic response in vivo,"HEMANN, MICHAEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$287,280"
Lymphoma,2008,NCI,5R03CA132153-02,,Risk Factors for Molecularly Defined Subgroups of Lymphoma: A Pooled Analysis,"CHIU, BRIAN",NORTHWESTERN UNIVERSITY,IL,"$77,288"
Lymphoma,2008,NCI,5R01CA047006-21,,Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$543,770"
Lymphoma,2008,NCI,5R41CA130547-02,,Lentiviral Redirected T Cells for B Cancer Immunotherapy,"RILEY, JAMES",LENTIGEN CORPORATION,MD,"$148,503"
Lymphoma,2008,NCI,5R01CA112211-02,,SPONTANEOUS CANINE MODELS FOR CANCER GENE DISCOVERY,"BREEN, MATTHEW",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$283,547"
Lymphoma,2008,NCI,2P50CA100707-06,0009,P-5: Molecular markers of plasma cell neoplasm evolution,"FONSECA, RAFAEL","MAYO CLINIC COLL OF MED, MAYO CLINIC AZ",AZ,"$159,212"
Lymphoma,2008,NCI,1P50CA130805-01A1,0001,P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas,"MAHADEVAN, DARUKA",UNIVERSITY OF ARIZONA,AZ,"$237,512"
Lymphoma,2008,NCI,1P50CA130805-01A1,0002,P- 2: Optimizing Redox Modulation as a Therapeutic Strategy for NHL,"BERNSTEIN, STEVEN",UNIVERSITY OF ROCHESTER,NY,"$172,343"
Lymphoma,2008,NCI,1P50CA130805-01A1,0003,P- 3:  Potentiating Proteasome Inhibitor Activity in NHL,"FRIEDBERG, JONATHAN",UNIVERSITY OF ROCHESTER,NY,"$263,148"
Lymphoma,2008,NCI,1P50CA130805-01A1,0004,P-4: Characterization of Lymphoma-Initiating Cells,"JORDAN, CRAIG",UNIVERSITY OF ROCHESTER,NY,"$165,652"
Lymphoma,2008,NCI,1P50CA130805-01A1,9001,CB: Tissue Core,"RIMSZA, LISA",UNIVERSITY OF ARIZONA,AZ,"$254,626"
Lymphoma,2008,NCI,1P50CA130805-01A1,9004,CA: Administration Core,"FISHER, RICHARD",UNIVERSITY OF ROCHESTER,NY,"$197,325"
Lymphoma,2008,NCI,1P50CA130805-01A1,9002,CC: Clinical Trials Core,"FRIEDBERG, JONATHAN",UNIVERSITY OF ROCHESTER,NY,"$235,416"
Lymphoma,2008,NCI,1P50CA130805-01A1,0005,Developmental Research Program,"LAND, HARTMUT",UNIVERSITY OF ROCHESTER,NY,"$45,786"
Lymphoma,2008,NCI,1P50CA130805-01A1,0006,Career Development Program,"FISHER, SUSAN",UNIVERSITY OF ROCHESTER,NY,"$60,510"
Lymphoma,2008,NIAID,1R21AI079373-01,,Deletion of inhibitory genes in post-thymic T cells to study immune tolerance,"GAJEWSKI, THOMAS",UNIVERSITY OF CHICAGO,IL,"$231,000"
Lymphoma,2008,NIDA,1R21DA025157-01,,Harnessing Somatic Hypermutation for Drug Addiction Research,"GU, HOWARD",OHIO STATE UNIVERSITY,OH,"$150,000"
Lymphoma,2008,NCI,1R03CA135528-01,,Characterization of Atmtm1Awb Congenic Strains,"WEIL, MICHAEL",COLORADO STATE UNIVERSITY-FORT COLLINS,CO,"$73,500"
Lymphoma,2008,NIAID,1K25AI079404-01,,Light Weight Modeling of Epstein Barr Virus,"SHAPIRO, MICHAEL",TUFTS UNIVERSITY BOSTON,MA,"$124,632"
Lymphoma,2008,NCI,7K99CA126186-02,,Functions of microRNAs in lymphomagenesis,"HE, LIN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$114,782"
Lymphoma,2008,NCI,1R01CA135531-01,,Inflammation-regulated microRNA in B cell lymphoma,"RICKERT, ROBERT",BURNHAM INSTITUTE FOR MEDICAL RESEARCH,CA,"$381,207"
Lymphoma,2008,NCI,9R01CA137488-14A1,,Two Compartment Models to Improve Brain Tumor Therapy,"NEUWELT, EDWARD",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$494,277"
Lymphoma,2008,NCI,2R01CA108609-04A2,,Anti-viral DC/NK interactions,"MUNZ, CHRISTIAN",ROCKEFELLER UNIVERSITY,NY,"$283,786"
Lymphoma,2008,NCI,2R01CA056764-14A1,,Activation of BCL-2 in Hematologic Malignancies,"BOXER, LINDA","PALO ALTO INSTITUTE FOR RES & EDU, INC.",CA,"$290,500"
Lymphoma,2008,NCI,1R01CA131027-01A1,,Chimeric T Cell for Therpay of Hodgkin Disease,"SAVOLDO, BARBARA",BAYLOR COLLEGE OF MEDICINE,TX,"$308,743"
Lymphoma,2008,NHLBI,2R01HL076799-05,,"Inflammatory Proteases, Ubiquitin Proteasome System, and Myocyte Death","SABRI, ABDELKARIM",TEMPLE UNIVERSITY,PA,"$362,500"
Lymphoma,2008,NCI,2R01CA093853-06A1,,The role of p63 and p73 in cancer,"MOLL, UTE",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$235,373"
Lymphoma,2008,NCI,1R01CA129962-01A1,,Heat shock protein 90 antagonist-based therapy of mantle cell lymphoma,"BHALLA, KAPIL",MEDICAL COLLEGE OF GEORGIA (MCG),GA,"$305,025"
Lymphoma,2008,NCI,1R01CA116481-01A1,,The Role of Fbxw7 in genetic instability and cancer,"MAO, JIAN-HUA",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$320,588"
Lymphoma,2008,NCI,1R01CA127530-01A1,,The role of protein kinase PKK in BAFF signaling and B-cell malignancies,"ZHAO, JIYONG",UNIVERSITY OF ROCHESTER,NY,"$319,550"
Lymphoma,2008,NCI,1R01CA124596-01A1,,Oncogenes and oncogenic microRNAs in chicken tumors,"BEEMON, KAREN",JOHNS HOPKINS UNIVERSITY,MD,"$335,536"
Lymphoma,2008,NCI,1R21CA133876-01A1,,Clinical Activity of MGCD-0103 in Hodgkin Lymphoma,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$250,200"
Lymphoma,2008,NCI,1R21CA132279-01A1,,EBV-Specific T-Cell Therapy for Nasopharynx Cancer: Immunomodulation and Response,"POSNER, MARSHALL",DANA-FARBER CANCER INSTITUTE,MA,"$388,730"
Lymphoma,2008,NIDCR,1R21DE017136-01A2,,Sjogren's Syndrome Associated B-cell lymphomagenesis,"BAHLER, DAVID",UNIVERSITY OF UTAH,UT,"$238,662"
Lymphoma,2008,NIDCR,1R01DE019249-01,,Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma,"ELENITOBA-JOHNSON, KOJO",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$386,250"
Lymphoma,2008,NICHD,1R03HD052526-01A2,,The mechanism of Notch signaling pathway in radial glial development,"KATO, YOICHI",FLORIDA STATE UNIVERSITY,FL,"$73,500"
Lymphoma,2008,NCI,1R03CA125827-01A2,,Space-Time Clustering of Non-Hodgkin's Lymphoma Using Residential Histories,"MELIKER, JAYMIE",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$84,368"
Lymphoma,2008,NCI,1R01CA133063-01A1,,Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$274,204"
Lymphoma,2008,NIAID,1R21AI079800-01,,Altered somatic mutation in IgAD/CVID; association with deficiency of Msh4/5,"SEKINE, HIDEHARU",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$221,250"
Lymphoma,2008,NIAID,1R03AI079797-01,,Investigations into XIAP-deficient X-linked Lymphoproliferative Disease,"MARSH, REBECCA",CHILDREN'S HOSPITAL MED CTR (CINCINNATI),OH,"$75,000"
Lymphoma,2008,NCI,1R43CA134108-01A1,,Development of a Small Molecule-Targeted Therapy for Mantle Cell Lymphoma,"MANIAR, MANOJ","ONCONOVA THERAPEUTICS, INC.",PA,"$220,180"
Lymphoma,2008,NCI,2R44CA108083-02A2,,An anti-CD74 MAb-drug conjugate for B-cell malignancies,"GOVINDAN, SERENGULAM","IMMUNOMEDICS, INC.",NJ,"$492,190"
Lymphoma,2008,NCI,1F32CA130469-01A2,,The role of cellular miRNA in Epstein-Barr virus oncogenesis,"CAMERON, JENNIFER",TULANE UNIVERSITY OF LOUISIANA,LA,"$52,898"
Lymphoma,2008,NCI,1R03CA136064-01,,Outcomes of Curable Cancers in Vulnerable Populations,"KOROUKIAN, SIRAN",CASE WESTERN RESERVE UNIVERSITY,OH,"$27,475"
Lymphoma,2008,NCI,1R21CA128560-01A2,,Role of Cyclooxygenase-2 and PGE2 in KSHV pathogenesis,"SHARMA-WALIA, NEELAM",ROSALIND FRANKLIN UNIV OF MEDICINE & SCI,IL,"$190,575"
Lymphoma,2008,NINDS,1R03NS060647-01A2,,Migration of polyomavirus JC across the blood-brain-barrier,"NERURKAR, VIVEK",UNIVERSITY OF HAWAII AT MANOA,HI,"$76,750"
Lymphoma,2008,RMAP,1R21NS063905-01,,Small Molecule Inhibitors of K13-Induced NF-kB Activation,"CHAUDHARY, PREET",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$151,251"
Lymphoma,2008,NCI,7R01CA113969-04,,RhoH GTPase in Hematopoiesis and Cancer,"WILLIAMS, DAVID",CHILDREN'S HOSPITAL BOSTON,MA,"$316,480"
Lymphoma,2008,NCI,3R01CA047763-20S1,,Transformation of Cells by the REL Oncogene,"GILMORE, THOMAS",BOSTON UNIVERSITY,MA,"$10,000"
Lymphoma,2008,RMAP,1R21NS063906-01,,Assay For Inhibitors of Epstein-Barr Virus,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$140,948"
Lymphoma,2008,NCI,5P01CA113239-03,0002,P-2: LANA-1 mediated negative regulation of gene expression,"HAYWARD, S",JOHNS HOPKINS UNIVERSITY,MD,"$286,996"
Lymphoma,2008,NCI,5P01CA113239-03,0003,P-3:Viral Chemokine signalling in HHV-8 infection,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$293,977"
Lymphoma,2008,NCI,3R01CA095043-05S1,,Activation of the LMP-1 Protein of Epstein-Barr Virus,"MARTIN, JENNIFER",UNIVERSITY OF COLORADO AT BOULDER,CO,"$46,501"
Lymphoma,2008,NCI,5P01CA078902-10,0006,Mixed Chimerism in the Treatment of B-Cell Malignancies,"MALONEY, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$193,569"
Lymphoma,2008,NHLBI,5P50HL074732-05,0002,Transplant EBV Disease:  Pathogenesis and Immunotherapy,"ROWE, DAVID",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$403,932"
Lymphoma,2008,NCI,1R03CA137757-01,,Relationship of 6 (Q)(22) to Survival in Primary CNS Lymphoma,"O'NEILL, BRIAN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$75,550"
Lymphoma,2008,NCI,1R03CA137828-01,,Hodgkin Lymphoma Consortium: Pooling epidemiologic data for a research resource,"GLASER, SALLY",NORTHERN CALIFORNIA CANCER CENTER,CA,"$72,500"
Lymphoma,2008,NCI,5P01CA042045-21,0011,Lymphoma and Its Response to Treatment,"EARY, JANET",UNIVERSITY OF WASHINGTON,WA,"$139,731"
Lymphoma,2008,NCI,3R01CA111807-04S1,,The Role of Toll-Like Receptors in Cancer Immunotherapy,"YANG, YIPING",DUKE UNIVERSITY,NC,"$53,973"
Lymphoma,2008,NCI,3D43TW000013-21S1,,UCLA Fogarty AITRP: Research Training Program in AIDS-related Malignancies,"DETELS, ROGER",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$149,040"
Lymphoma,2008,NCI,3D43TW000231-14S1,,Building Capacity for Patient Oriented Research in HIV-associated Kaposi Sarcoma,"ABDOOL KARIM, QUARRAISHA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$131,919"
Lymphoma,2008,NCI,5P01CA016519-33,0008,REGULATION OF V(D)J RECOMBINATION IN CELL CYCLE AND IN DEVELOPMENT,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$265,756"
Lymphoma,2008,NCI,5P01CA049605-20,0002,Autografting for Lymphoma,"HORNING, SANDRA",STANFORD UNIVERSITY,CA,"$373,636"
Lymphoma,2008,NCI,5P01CA049605-20,0010,Non-Myeloablative Host Conditioning that Protects Against GVHD,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$311,594"
Lymphoma,2008,NIDCR,1F31DE019599-01,,Early events in infection of epithelial cells with Epstein-Barr Virus,"VALENCIA, SARAH",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$26,231"
Lymphoma,2008,NCI,1F31CA134207-01A1,,Translational Control of Cancer,"UNDERWOOD, JON",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$27,193"
Lymphoma,2008,NCI,5P01CA034233-24,0032,In Situ Vaccination for Lymphoma by Intratumoral Injection of Immunostimulatory,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$399,138"
Lymphoma,2008,NCI,5P01CA034233-24,0033,Intracellular Signaling in Malignant Lymphoma Cells,"NOLAN, GARRY",UNIVERSITY OF MIAMI CORAL GABLES,FL,"$396,645"
Lymphoma,2008,NCI,5P01CA034233-24,9002,"Diagnosis, Tissue Acquisition, Banking Distribution","LEVY, RONALD",STANFORD UNIVERSITY,CA,"$206,565"
Lymphoma,2008,NCI,5P01CA034233-24,9003,Statistics and Data Management,"TIBSHIRANI, ROBERT",STANFORD UNIVERSITY,CA,"$313,260"
Lymphoma,2008,NCI,5P01CA015396-33,0020,Hodgkin's Lymphoma Stem Cells,"AMBINDER, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$353,501"
Lymphoma,2008,NCI,5P01CA019014-30,0021,TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2 (LMP1 AND LMP2),"RAAB-TRAUB, NANCY",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$350,326"
Lymphoma,2008,NCI,5P01CA019014-30,0023,CELLULAR AND VIRAL REGULATION OF TYPE III EBV LATENCY,"PAGANO, JOSEPH",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$337,644"
Lymphoma,2008,NCI,5P30CA015083-34,9020,CORE-- Protocol-Specific Research Support,"ADJEI, ALEX","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$236,631"
Lymphoma,2008,NCI,5P30CA015083-34,9030,CORE--BIOSPECIMENS ACCESSIONING AND PROCESSING,"HIGHSMITH, EDWARD","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$325,120"
Lymphoma,2008,NCI,5U19CA113298-04,0001,Optimization and Characterization of Targeting Agents for Lymphoid Malignancies,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$410,842"
Lymphoma,2008,NCI,5U19CA113298-04,0003,"Lymphoma-Specific Ligands; Pharmacokinetics, Radioimaging and Therapeutics","DENARDO, SALLY",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$335,155"
Lymphoma,2008,NCI,5U19CA113298-04,9001,Core--Synthetic Chemistry,"KURTH, MARK",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$165,524"
Lymphoma,2008,NCI,5P01CA044991-21,0001,Radiolabeled Antibody Therapy of B-Cell Lymphoma,"GOPAL, AJAY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$92,832"
Lymphoma,2008,NCI,5P01CA044991-21,0006,Improved Targeting Strategies,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$440,200"
Lymphoma,2008,OD,2R56CA104996-05,,Promoting Tumor Immunity by Cross-Linking B7-DC,"PEASE, LARRY","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$236,246"
Lymphoma,2008,NCI,4R33CA103548-03,,PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS,"JAY, DANIEL",TUFTS UNIVERSITY BOSTON,MA,"$658,595"
Lymphoma,2008,NCI,5P30CA124435-02,0016,CANCER IMAGING RESOURCE,"DOYLE, TIMOTHY",STANFORD UNIVERSITY,CA,"$61,167"
Lymphoma,2008,NCI,5P01CA030206-26,0020,Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and,"FORMAN, STEPHEN",CITY OF HOPE NATIONAL MEDICAL CENTER,CA,"$1,031,002"
Lymphoma,2008,NCI,3R01CA088768-09S1,,Structure and Molecular Composition of KSHV an RRV,"KEDES, DEAN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$51,474"
Lymphoma,2008,NCI,7R01CA106550-05,,The Tumor Suppression Potential of NF-kappaB2 p100,"DING, HAN-FEI",MEDICAL COLLEGE OF GEORGIA (MCG),GA,"$220,224"
Lymphoma,2008,NCI,3R01CA071768-12S1,,Redox Control of Apoptosis Signaling,"BRIEHL, MARGARET",UNIVERSITY OF ARIZONA,AZ,"$51,704"
Lymphoma,2008,NIAID,7K99AI072956-02,,"Roles for TAK1 in T cell development, function and tumorigenesis","WAN, YISONG",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$89,999"
Lymphoma,2008,NHLBI,5P01HL065608-08,0005,Stat3 in Post-Ischemic Myocardial Inflammation,"BECKER, LEWIS",JOHNS HOPKINS UNIVERSITY,MD,"$362,932"
Lymphoma,2008,NIAID,2R56AI055599-06A1,,Characterization of V(D)J cleavage and repair complexes,"SWANSON, PATRICK",CREIGHTON UNIVERSITY,NE,"$289,000"
Lymphoma,2008,NIAID,3U54AI057156-05S1,0041,Passive Immunotherapeutics for Select Agents,"PETERS, CLARENCE",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$269,297"
Lymphoma,2008,NCI,5P01CA059350-15,0005,Artif. Antigen Presentation to Sensitize Virus-Spec. TCells for Adoptive Immunoth,"O'REILLY, RICHARD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$367,027"
Lymphoma,2008,NCI,5P01CA059350-15,9003,Imaging Core,"BLASBERG, RONALD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$248,203"
Lymphoma,2008,NCI,5P50CA097274-07,0001,A Novel Approach to the Immunotherapy of B Cell Malignancy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$229,794"
Lymphoma,2008,NCI,5P50CA097274-07,0002,Signal Transduction Inhibitor Therapy for Lymphoma,"WITZIG, THOMAS",UNIVERSITY OF IOWA,IA,"$309,922"
Lymphoma,2008,NCI,5P50CA097274-07,0003,Biology and Epidemiology of APRIL and Blys in B-cell and NHL,"CERHAN, JAMES",UNIVERSITY OF IOWA,IA,"$373,113"
Lymphoma,2008,NCI,5P50CA097274-07,0004,Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin,"ANSELL, STEPHEN",UNIVERSITY OF IOWA,IA,"$287,478"
Lymphoma,2008,NCI,5P50CA097274-07,0005,Developmental Research Program,"RATLIFF, TIMOTHY",UNIVERSITY OF IOWA,IA,"$174,267"
Lymphoma,2008,NCI,5P50CA097274-07,0006,Career Development Program,"HOHL, RAYMOND",UNIVERSITY OF IOWA,IA,"$95,913"
Lymphoma,2008,NCI,5P50CA097274-07,9001,Biospecimens,"DOGAN, AHMET",UNIVERSITY OF IOWA,IA,"$274,833"
Lymphoma,2008,NCI,5P01CA109901-05,0002,Molecular Pathways in T Cell Development and Thymic Lymphoma,"VON BOEHMER, HARALD",DANA-FARBER CANCER INSTITUTE,MA,"$298,416"
Lymphoma,2008,NCI,5P01CA109901-05,0004,Role of H2AX and ATM in Suppression of Thymic Lymphomas,"ALT, FREDERICK",DANA-FARBER CANCER INSTITUTE,MA,"$558,569"
Lymphoma,2008,NCI,5P01CA017054-30,0002,HT and Risk of Non-Hodgkin;s Lymphoma (NHL),"BERNSTEIN, LESLIE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$632,878"
Lymphoma,2008,NCI,5P01CA017054-30,9001,CORE--CSP Cancer Surveillance,"DEAPEN, DENNIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$129,479"
Lymphoma,2008,NCI,3R01CA057152-14S1,,Immune Dysfunction and AIDS-associated B Cell Lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$163,086"
Lymphoma,2008,NCI,3R01CA109524-03S1,,IL-7 and Lymphocyte Homeostasis: Life versus Death,"KHALED, ANNETTE",UNIVERSITY OF CENTRAL FLORIDA,FL,"$43,120"
Lymphoma,2008,NCI,5U54CA119367-03,0005,Biological Modification of Quantum Dots for in vivo Imaging,"WU, ANNA",STANFORD UNIVERSITY,CA,"$459,429"
Lymphoma,2008,NCI,5U54CA119367-03,0006,Mouse Cancer Models for Integrated Tissue/Serum Proteomics and Molecular Imaging,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$631,555"
Lymphoma,2008,NCI,3R21CA110953-02S1,,Flavopiridol / Bortezomib in Myeloma / B-Cell Neoplasms,"GRANT, STEVEN",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$37,250"
Lymphoma,2008,NCI,5P50CA094056-08,0003,Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$241,335"
Lymphoma,2008,NCI,5P01CA016038-35,0001,Biology of the Epstein-Barr Virus R Transactivator in Human B Cells,"MILLER, GEORGE",YALE UNIVERSITY,CT,"$436,111"
Lymphoma,2008,NCI,2P30CA013696-35,0009,LYMPHOID DVLP AND MALIGNANCIES (LDM),"O'CONNOR, OWEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$20,848"
Lymphoma,2008,NCI,2P30CA013696-35,9038,PROTOCOL SPECIFIC RESEARCH RESOURCE,"GELMANN, EDWARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$65,930"
Lymphoma,2008,NCI,3R01CA124332-02S1,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$76,713"
Lymphoma,2008,NCI,5P30CA016359-30,0003,Research Programs-Immunology and Immunotherapy,"MELLMAN, IRA",YALE UNIVERSITY,CT,"$30,003"
Lymphoma,2008,OD,2R56HD018055-21A1,,Genetic Analysis of Polarity,"STEWARD, RUTH",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$319,511"
Lymphoma,2008,NCI,5P50CA126752-02,0001,Immunotherapy for Hodgkin's Disease,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$245,785"
Lymphoma,2008,NCI,5P50CA126752-02,0002,Chimeric T Cell Antigens Targeting Kappa in B Cell Lymphoma,"DOTTI, GIANPIETRO",BAYLOR COLLEGE OF MEDICINE,TX,"$256,857"
Lymphoma,2008,NCI,5P50CA126752-02,0003,T Cell Therapy Targeting LMP1 and 2 in EBV+VE Lymphomas,"GOTTSCHALK, STEPHEN",BAYLOR COLLEGE OF MEDICINE,TX,"$257,740"
Lymphoma,2008,NCI,5P50CA126752-02,0004,Regulatory T Cells and Toll-Like Receptor Signaling in Lymphoma Therapy,"RONGFU, WANG",BAYLOR COLLEGE OF MEDICINE,TX,"$258,282"
Lymphoma,2008,NCI,5P50CA126752-02,0006,Research Development,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$158,635"
Lymphoma,2008,NCI,5P50CA126752-02,0007,Career Development,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$158,636"
Lymphoma,2008,NCI,5P50CA126752-02,9002,Biostatistics and Data Management,"WEISS, HEIDI",BAYLOR COLLEGE OF MEDICINE,TX,"$122,832"
Lymphoma,2008,NCI,5P50CA126752-02,9003,Cell and Vector Production,"GEE, ADRIAN",BAYLOR COLLEGE OF MEDICINE,TX,"$151,560"
Lymphoma,2008,NCI,5P50CA126752-02,9004,Tissue Resource,"GRESIK, VICTORIA",BAYLOR COLLEGE OF MEDICINE,TX,"$330,402"
Lymphoma,2008,NCI,5P50CA093372-07,0004,Immunotherapy of Cutaneous T-Cell Lymphoma with Interleukin-12,"ROOK, ALAIN",WISTAR INSTITUTE,PA,$3
Lymphoma,2008,NCI,5P30CA068485-13,9004,DNA MICROARRAY SHARED RESOURCES,"LEVY, SHAWN",VANDERBILT UNIVERSITY,TN,"$352,277"
Lymphoma,2008,NCI,5P30CA013330-36,9032,IMMUNO-ONCOLOGY,"SCHARFF, MATTHEW",YESHIVA UNIVERSITY,NY,"$34,631"
Lymphoma,2008,NCI,3R01CA057152-14S2,,Immune Dysfunction and AIDS-associated B Cell Lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$123,200"
Lymphoma,2008,NCI,5P01CA087497-08,0003,p53 and Chemosensitivity in a Mouse Lymphoma Model,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$394,677"
Lymphoma,2008,NIAID,1R56AI073215-01A1,,Mechanisms of Gene Regulation by EBV EBNA-1 Protein,"SAMPLE, JEFFERY",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$379,236"
Lymphoma,2008,NCI,5P50CA107399-05,0001,Anti-CD30 Radioimmunotherapy of Hodgkin's Lymphoma & CD30+ NonHodgkin's Lymphoma,"RAUBITSCHEK, ANDREW",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$138,679"
Lymphoma,2008,NCI,5P50CA107399-05,0002,Cellular Immunotherapy for Follicular Lymphoma Using CD19- Specific T-Cells,"JENSEN, MICHAEL",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$104,098"
Lymphoma,2008,NCI,5P50CA107399-05,0003,Therapy-Related Leukemia Following Autologous Transplantation for Lymphoma,"BHATIA, RAVI",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$335,563"
Lymphoma,2008,NCI,5P50CA107399-05,0004,Molecularly Engineered Constructs for anti-CD20 Directed Therapeutics,"RAUBITSCHEK, ANDREW",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$340,858"
Lymphoma,2008,NCI,5P50CA107399-05,9002,Tissue Bank for Cellular and Molecular Studies,"WEISS, LAWRENCE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$218,751"
Lymphoma,2008,NCI,5P50CA107399-05,9005,Developmental Research Program,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$154,005"
Lymphoma,2008,NCI,5P50CA107399-05,9006,Career Development Program,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$154,005"
Lymphoma,2008,NCI,5P01CA095426-07,0005,INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$478,215"
Lymphoma,2008,NCI,5P01CA095426-07,9003,MOUSE MODELING AND ANIMAL DEVELOPMENT,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$239,562"
Lymphoma,2008,NCI,5U54CA119343-04,0002,"""Smart"" Nanoparticles for Cancer Therapy and Imaging","DESIMONE, JOSEPH",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$308,821"
Lymphoma,2008,NCI,3U01CA121947-03S1,,AIDS Malignancy Clinical Trials Consortium,"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$249,599"
Lymphoma,2008,OD,3U01CA121947-03S2,,AIDS Malignancy Clinical Trials Consortium,"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$25,000"
Lymphoma,2008,NCI,3U01CA121947-03S3,,AIDS Malignancy Clinical Trials Consortium,"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$250,067"
Lymphoma,2008,NCI,5P01CA042063-23,0011,Cancer and Gene Regulation by Short RNAs,"SHARP, PHILLIP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$469,604"
Lymphoma,2008,NCI,3U56CA112973-03S2,,Computational Modeling of Cancer Biology,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$536,586"
Lymphoma,2008,NCI,5P01CA013106-37,0007,Regulation of Pre-mRNA Splicing in Tumorigenesis,"KRAINER, ADRIAN",COLD SPRING HARBOR LABORATORY,NY,"$607,522"
Lymphoma,2008,NCI,5P01CA013106-37,0027,microRNAs in Human Cancer,"HANNON, GREGORY",COLD SPRING HARBOR LABORATORY,NY,"$652,367"
Lymphoma,2008,NCI,5P01CA013106-37,0028,Tumor Suppression,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$718,040"
Lymphoma,2008,NCI,N01PC35143-17-0-8,,RRSS #2 Population-Based Lymphoma Pharmacosurveillance: Proof-of-Principle - Iowa,NO PI IDENTIFIED,UNIVERSITY OF IOWA,IA,"$204,601"
Lymphoma,2008,NCI,2P30CA016059-28,9029,Protocol-Specific Research Support,"GINDER, GORDON",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$19,142"
Lymphoma,2008,NCI,261200800001E-2-0-36,,Repository Services for epidemiology studies,NO PI IDENTIFIED,,,"$15,287"
Lymphoma,2008,NCI,2P30CA014599-33,9023,HUMAN IMMUNOLOGIC MONITORING,"GAJEWSKI, THOMAS",UNIVERSITY OF CHICAGO,IL,"$80,536"
Lymphoma,2008,NCRR,2G12RR013459-11,5540,THE STUDY AND CHARACTERIZATION OF XENOESTROGEN EFFECTS,"NDEBELE, KENNETH",JACKSON STATE UNIVERSITY,MS,"$135,417"
Lymphoma,2008,NCRR,2P51RR000168-47,5588,PATHOGENESIS OF EPSTEIN-BARR VIRUS INFECTION,"WANG, FREDERICK",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$237,907"
Lymphoma,2008,NCRR,2P51RR000168-47,5650,DETERMINATION OF THE IMPORTANCE OF LMP2A IN PRIMARY EBV INFECTION,"LONGNECKER, RICHARD",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$237,907"
Lymphoma,2008,NCRR,2P51RR000168-47,5668,KSHV VIRF3 3 STABILIZES HIF1ALPHA TO INDUCE VEGF EXPRESSION,"SHIN, YOUNG",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$32,442"
Lymphoma,2008,NCRR,2P51RR000168-47,5669,HVS STP-C ONCOPROTEIN TARGETS TRAFS TO INDUCE CELL GROWTH TRANSFORMATION,"JUNG, JAE",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$32,442"
Lymphoma,2008,NCRR,2P51RR000168-47,5670,NON-HUMAN PRIMATE MODEL OF KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS INFECTION,"CHANG, HEESON",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$32,442"
Lymphoma,2008,NCRR,2P51RR000168-47,5672,INIBITION OF AUTOPHAGY AND APOPTOSIS BY MHV68 VBCL-2,"KU, BONSU",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$32,442"
Lymphoma,2008,NCRR,5P51RR000163-49,6022,RHESUS HHV8 HOMOLOGUE IN AIDS-RELATED MALIGNANCIES,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$171,722"
Lymphoma,2008,NIA,5P51RR000163-49,6022,RHESUS HHV8 HOMOLOGUE IN AIDS-RELATED MALIGNANCIES,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$4,419"
Lymphoma,2008,NCRR,5P51RR000163-49,6072,VALIDATING VIL-6 AS A TARGET FOR KSHV-ASSOCIATED DISEASE,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$34,426"
Lymphoma,2008,NIA,5P51RR000163-49,6072,VALIDATING VIL-6 AS A TARGET FOR KSHV-ASSOCIATED DISEASE,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,$886
Lymphoma,2008,NCRR,2M01RR000043-48,6755,CLINICAL TRIAL: PILOT/FEASIBILITY STUDY TO EVALUATE THE SAFETY OF CELLULAR,"JENSEN, MICHAEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$57,683"
Lymphoma,2008,NCRR,2M01RR000043-48,6756,CLINICAL TRIAL: A PILOT STUDY OF YTTRIUM-90-LABELED ANTI-CD20 MONOCLONAL,"KRISHNAN, AMRITA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$1,201"
Lymphoma,2008,NCRR,2M01RR000043-48,6768,A PHASE I STUDY OF BORTEZOMIB AND TEMOZOLOMIDE IN PATIENTS WITH REFRACTORY SOLID,"PORTNOW, JANA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$108,156"
Lymphoma,2008,NCRR,2M01RR000043-48,6784,A PILOT STUDY OF SAFETY AND FEASIBILITY OF STEM CELL THERAPY FOR AIDS,"KRISHNAN, AMRITA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$1,106"
Lymphoma,2008,NCRR,2M01RR000043-48,6805,A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS),"LEVINE, ALEXANDRA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$39,251"
Lymphoma,2008,NCRR,2M01RR000046-48,6996,SB-743971 IN PATIENTS WITH NON-HODGKINS,"VANDEVENTER, HANK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$3,367"
Lymphoma,2008,NCRR,5M01RR000400-40,7453,CLINICAL TRIAL: MT2003-03 CPG 7909 AFTER AUTOLOGOUS TRANSPLANTATION TO ENHANCE R,"TOMBLYN, MARCIE",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$21,643"
Lymphoma,2008,NCRR,5M01RR000400-40,7509,"MT2005-14-PHASE I OPEN LABEL, SINGLE ARM, DOSE ESCALATION TRIAL TO EVALUATE THE","BURNS, LINDA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$8,481"
Lymphoma,2008,NCRR,5M01RR000400-40,7574,MT2007-12: ALLOGENEIC NATURAL KILLER CELLS WITH RITUXIMAB IN PATIENTS WITH CD20,"BACHANOVAMD, VERONIKA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$3,114"
Lymphoma,2008,NCRR,5M01RR000750-36,7628,A PHARMACOKINETIC AND PHARMACOGENETIC STUDY OF CHEMOTHERAPEUTIC,"SWEENEY, CHRISTOPHER",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$1,047"
Lymphoma,2008,NCRR,5M01RR000188-44,7832,CLINICAL TRIAL: ADMINISTRATION OF LMP1 AND LMP2-SPECIFIC CYTOTOXIC T-LYMPHOCYTES,"GOTTSCHALK, STEPHEN",BAYLOR COLLEGE OF MEDICINE,TX,$223
Lymphoma,2008,NCRR,5M01RR000188-44,7843,CLINICAL TRIAL: ADMINISTRATION OF NEOMYCIN RESISTANCE GENE MARKED EBV SPECIFIC C,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,"$3,569"
Lymphoma,2008,NCRR,5M01RR000188-44,7847,CLINICAL TRIAL: EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR EBV-POSITIVE NASOPHARYN,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$18,516"
Lymphoma,2008,NCRR,5M01RR000188-44,7850,CLINICAL TRIAL: NEOMYCIN RESISTANCE LMP2A SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR E,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,"$13,162"
Lymphoma,2008,NCRR,5M01RR000188-44,7851,CLINICAL TRIAL: ADMINISTRATION OF  LMP2A-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOLLOW,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,$223
Lymphoma,2008,NCRR,5M01RR000188-44,7852,CLINICAL TRIAL: ADMINISTRATION OF EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOLLOWING,"GOTTSCHALK, STEPHEN",BAYLOR COLLEGE OF MEDICINE,TX,"$2,677"
Lymphoma,2008,NCRR,5M01RR000188-44,7865,CLINICAL TRIAL: ADMINISTRATION OF LMP1- AND LMP2-SPECIFIC CYTOTOXIC T-LYMPHOCYTE,"GOTTSCHALK, STEPHEN",BAYLOR COLLEGE OF MEDICINE,TX,"$17,538"
Lymphoma,2008,NCRR,5M01RR000070-46,7959,CLINICAL TRIAL: EVALUATE THE EFFICACY OF ANTI-CD20 ANTIBODY IN LYMPHOCYTE PREDOM,"HORNING, SANDRA",STANFORD UNIVERSITY,CA,"$3,641"
Lymphoma,2008,NCRR,5M01RR000070-46,7965,"CLINICAL TRIAL: KLH WITH GM-CSF, IN PATIENTS WITH FOLLICULAR NON-HODGKIN'S LYMPH","LEVY, RONALD",STANFORD UNIVERSITY,CA,$455
Lymphoma,2008,NCRR,5M01RR000070-46,7985,"CLINICAL TRIAL: ATLR 9 AGONIST, COMBINED WITH LOCAL RADIATION IN RECURRENT LOW-G","LEVY, RONALD",STANFORD UNIVERSITY,CA,"$9,784"
Lymphoma,2008,NCRR,5M01RR000070-46,7987,CLINICAL TRIAL: SGN-40 (ANTI-HUCD40 MAB) IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA,"ADVANI, RAJ",STANFORD UNIVERSITY,CA,$796
Lymphoma,2008,NCRR,5M01RR000070-46,7989,CLINICAL TRIAL: PHASE II STUDY OF BEXXAR IN RELAPSED/REFRACTORY DLCL,"KNOX, SUSAN",STANFORD UNIVERSITY,CA,$683
Lymphoma,2008,NCRR,5M01RR000070-46,8011,CLINICAL TRIAL: PXD101 IN RECURRENT OR REFRACTORY CUTANEOUS AND PERIPHERAL T-CEL,"ADVANI, RAJ",STANFORD UNIVERSITY,CA,"$3,527"
Lymphoma,2008,NCRR,5M01RR000865-35,8098,PHASE I/II STUDY OF ANTI-CTLA-4 MONOCLONAL ANTIBODY (MDX-010) IN FOLLICULAR N,"TIMMERMAN, JOHN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$1,069"
Lymphoma,2008,NCRR,5M01RR000865-35,8099,A PILOT STUDY OF INDUCING AND TARGETING EBV-TK IN EBV-POSITIVE LYMPHOMAS BY C,"DE VOS, SVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$13,190"
Lymphoma,2008,NCRR,5M01RR010732-14,8870,CLINICAL TRIAL: PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE,"EHMANN, CHRISTOPHER",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$1,217"
Lymphoma,2008,NCRR,5M01RR010732-14,5012,CLINICAL TRIAL: A RANDOMIZED PHASE III TRIAL OF ABVD VS STANDFORD V+/- RADIATION,"RYBKA, WITOLD",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$4,463"
Lymphoma,2008,NCRR,5M01RR010732-14,5093,CLINICAL TRIAL: PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE,"EHMANN, CHRISTOPHER",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$2,839"
Lymphoma,2008,NCRR,5P20RR016456-07,6125,GENETICS AND FUNCTIONS OF KSHV GLYCOPROTEINS GM AND GN,"D'AUVERGNE, OSWALD",LOUISIANA STATE UNIV A&M COL BATON ROUGE,LA,"$124,116"
Lymphoma,2008,NCRR,2P20RR018724-06,6694,LSUHSC COBRE:POLYAMINE METABOLISM IN EBV LYMPHOMAGENESIS,"SCOTT, RONA",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$321,824"
Lymphoma,2008,NCRR,2P20RR018789-06,6835,PROJECT 9: STEM CELL FUNCTION & GENOME INSTABILITY IN LYMPHOMYELOID NEOPLASIA,"MILLS, KEVIN",MAINE MEDICAL CENTER,ME,"$288,973"
Lymphoma,2008,NCRR,5P41RR001209-29,8246,NOVEL CHEMICAL SCAFFOLDS DISCOVERY USING STRUCTURE-DRIVEN CHEMISTRY,"ZHANG, KAM",STANFORD UNIVERSITY,CA,$184
Lymphoma,2008,NCRR,5P41RR013186-11,8815,DEVELOPMENT OF USER GUIDE & TUTORIAL FOR VIRTUAL CELL SOFTWARE,"SCHAFF, JAMES",UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,CT,"$27,639"
Lymphoma,2008,NCRR,5P41RR010888-12,5184,BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL,"DENIS, GERALD",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$5,837"
Lymphoma,2008,NCRR,5P41RR010888-12,5256,GENETIC AND BIOCHEMICAL STUDIES OF THE KSHV LANA GENE: AIDS OI,"KAYE, KENNETH",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$10,601"
Lymphoma,2008,NCI,5P01CA092625-08,0006,Molecular Mechanism of Translocations in B-Cell Lymphoma,"ALT, FREDERICK",DANA-FARBER CANCER INSTITUTE,MA,"$425,988"
Lymphoma,2008,NCI,5P01CA092625-08,0007,"The Role of B-Cell Receptor and NF
                                    RAJEWSKY, KLAUS
                                
                                    DANA-FARBER CANCER INSTITUTE
                                
                                    MA
                                
                                    $400,129","RAJEWSKY, KLAUS",DANA-FARBER CANCER INSTITUTE,MA,"$400,129"
Lymphoma,2008,NCI,5P01CA092625-08,0008,The Role of BCL-6 in Berminal Center Formation,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$399,230"
Lymphoma,2008,NCI,5P01CA092625-08,0009,Molecular Heterogeneity and Rational Thereapeutic Targets in Large B-Cell Lymphom,"SHIPP, MARGARET",DANA-FARBER CANCER INSTITUTE,MA,"$295,236"
Lymphoma,2008,NCI,5P01CA092625-08,0010,Targeting Deregulated Apoptotic and Transcriptional Programs in Lymphoma,"WALENSKY, LOREN",DANA-FARBER CANCER INSTITUTE,MA,"$310,759"
Lymphoma,2008,NCI,5P01CA092625-08,0011,Genomics and Bioinformatics,"GOLUB, TODD",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$326,494"
Lymphoma,2008,NCI,5P01CA092625-08,0012,Hematopathology,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$365,115"
Lymphoma,2008,NCI,5P01CA033049-25,0016,Strategies to Enhance Post-Transplant Tumor Vaccination,"VAN DEN BRINK, MARCEL",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$173,940"
Lymphoma,2008,NCI,5P01CA103985-04,8069,Biospecific Antibody Pretargeting for NHL,"SHARKEY, ROBERT",CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY,NJ,"$100,586"
Lymphoma,2008,NCI,5P01CA103985-04,8070,Radioimmunotherapy of B-cell Malignancies,"MATTES, M",CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY,NJ,"$108,384"
Lymphoma,2008,NCI,5P01CA103985-04,8071,Mechanisms of Serotherapy of B-Cell Malignancies,"CZUCZMAN, MYRON",CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY,NJ,"$230,032"
Lymphoma,2008,NCI,5P01CA103985-04,8072,Clinical Trials of NHL,"GOLDENBERG, DAVID",CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY,NJ,"$90,931"
Lymphoma,2008,NCI,5P01CA103985-04,8077,Histology/Immunohistology,"GOLD, DAVID",CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY,NJ,"$65,832"
Lymphoma,2008,NCI,5P50CA086438-08,0005,Imaging T Cell Interactions in Adoptive Therapy of EBV-Associated Malignancies,"BLASBERG, RONALD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$122,643"
Lymphoma,2008,NCI,5P50CA086438-08,0010,Developmental Research Program,"JURCIC, JOSEPH",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$87,119"
Lymphoma,2008,NIA,1Z01AG000166-07,,Characterization Of TGF-b Signaling In a B-cell Lymphoma Cell Line,"LONGO, DAN",NIH,,"$329,476"
Lymphoma,2008,NIA,1Z01AG000685-01,,Pattern recognition in medical imaging,"GOLDBERG, ILYA",NIH,,"$269,583"
Lymphoma,2008,NIA,1Z01AG000770-05,,Chemoattractant-based immunotherapeutics to modulate immune and cancer cells,"BIRAGYN, ARYA",NIH,,"$214,480"
Lymphoma,2008,NIAID,1Z01AI000732-14,,"Clinical, Immunological and Genetic  Analyses of ALPS","RAO, VEMULKONDA",NIH,,"$715,908"
Lymphoma,2008,NIAID,1Z01AI000858-09,,Lymphomas And Retroviral Pathogenesis,"MORSE, HERBERT",NIH,,"$876,014"
Lymphoma,2008,NIAID,1Z01AI000978-03,,Herpesvirus Pathogenesis and Vaccine Development,"COHEN, JEFFREY",NIH,,"$310,227"
Lymphoma,2008,NIAID,1Z01AI001070-01,,Targeted Killing of Herpesvirus-Infected Cells,"BERGER, EDWARD",NIH,,"$294,681"
Lymphoma,2008,NIAMS,1Z01AR041148-04,,AID biology,"CASELLAS, RAFAEL",NIH,,"$892,886"
Lymphoma,2008,NCI,1Z01BC008727-30,,Gene Expression and Signal Transduction in Transformation and Differentiation,"MUSHINSKI, J",NIH,,"$399,968"
Lymphoma,2008,NCI,1Z01BC010008-13,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$406,240"
Lymphoma,2008,NCI,1Z01BC010283-11,,DNA Repair,"NUSSENZWEIG, ANDRE",NIH,,"$788,201"
Lymphoma,2008,NCI,1Z01BC010301-11,,Development of Recombinant Toxins to Treat Hematologic Malignancies,"KREITMAN, ROBERT",NIH,,"$744,746"
Lymphoma,2008,NCI,1Z01BC010391-09,,Role of Trk Receptors in the Development and Function of Non-neuronal Structures,"TESSAROLLO, LINO",NIH,,"$588,598"
Lymphoma,2008,NCI,1Z01BC010603-05,,Receptor-directed Therapy,"JANIK, JOHN",NIH,,"$1,426,655"
Lymphoma,2008,NCI,1Z01BC010621-05,,Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,"BATES, SUSAN",NIH,,"$759,429"
Lymphoma,2008,NCI,1Z01BC010630-05,,Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,"JANIK, JOHN",NIH,,"$475,552"
Lymphoma,2008,NCI,1Z01BC010688-04,,Dermatology Consultation Clinic and Clinical Research,"TURNER, MARIA",NIH,,"$826,240"
Lymphoma,2008,NCI,1Z01BC010715-03,,Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"WILSON, WYNDHAM",NIH,,"$225,107"
Lymphoma,2008,NCI,1Z01BC010716-03,,Phase III study of BCL-family inhibitors in lymphoma,"WILSON, WYNDHAM",NIH,,"$225,107"
Lymphoma,2008,NCI,1Z01BC010717-03,,Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"WILSON, WYNDHAM",NIH,,"$112,553"
Lymphoma,2008,NCI,1Z01BC010719-03,,Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"WILSON, WYNDHAM",NIH,,"$112,553"
Lymphoma,2008,NCI,1Z01BC010728-03,,Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"WILSON, WYNDHAM",NIH,,"$112,553"
Lymphoma,2008,NCI,1Z01BC010779-02,,Regulation and Consequences of Ubiquitination,"ASHWELL, JONATHAN",NIH,,"$575,927"
Lymphoma,2008,NCI,1Z01BC010856-02,,Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,"CUSTER, MARY",NIH,,"$16,430,794"
Lymphoma,2008,NCI,1Z01BC010885-01,,Study of tumor pathogenesis and development of therapies for AIDS-malignancies,"YARCHOAN, ROBERT",NIH,,"$662,698"
Lymphoma,2008,NCI,1Z01BC010888-01,,Clinical trials of patients with AIDS-related malignancies,"YARCHOAN, ROBERT",NIH,,"$905,688"
Lymphoma,2008,NCI,1Z01BC010911-01,,Role of Novel MicroRNAs in the PVT-1 Locus,"MUSHINSKI, J.",NIH,,"$177,763"
Lymphoma,2008,NCI,1Z01BC010924-01,,Pathogenesis of cutaneous T cell lymphoma,"HWANG, SAM",NIH,,"$224,595"
Lymphoma,2008,NCI,1Z01BC010925-01,,Phase I Study of Topical Romidepsin in Early Stage Cutaneous T-cell Lymphoma,"KONG, HEIDI",NIH,,"$9,365"
Lymphoma,2008,NCI,1Z01BC010930-01,,Molecular Cytogenetics Core,"ROSCHKE, ANNA",NIH,,"$373,785"
Lymphoma,2008,NCI,1Z01BC011006-01,,Molecular diagnosis and outcome prediction in lymphoma,"STAUDT, LOUIS",NIH,,"$770,465"
Lymphoma,2008,NCI,1Z01BC011007-01,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$770,465"
Lymphoma,2008,NCI,1Z01BC011008-01,,Oncogenic mechanisms and molecular targets in lymphoma,"STAUDT, LOUIS",NIH,,"$770,465"
Lymphoma,2008,NCI,1Z01BC011029-01,,Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant,"HAKIM, FRANCES",NIH,,"$175,358"
Lymphoma,2008,NCI,1Z01BC011064-01,,A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,"MOCK, BEVERLY",NIH,,"$304,680"
Lymphoma,2008,NCI,1Z01BC011065-01,,Preclinical Testing of HDAC and mTOR Inhibitors,"MOCK, BEVERLY",NIH,,"$304,680"
Lymphoma,2008,NCI,1Z01BC011070-01,,Hematopathology diagnosis and education,"JAFFE, ELAINE",NIH,,"$736,790"
Lymphoma,2008,NCI,1Z01BC011079-01,,Molecular Diagnostics Core Laboratory,"RAFFELD, MARK",NIH,,"$1,422,634"
Lymphoma,2008,NCI,1Z01BC011087-01,,Immunohistochemistry Core Laboratory,"RAFFELD, MARK",NIH,,"$406,467"
Lymphoma,2008,NCI,1Z01BC011093-01,,FLow Cytometric Detection of Malignant Cells in Body Fluids,"STETLER-STEVENSON, MARYALICE",NIH,,"$367,503"
Lymphoma,2008,NCI,1Z01BC011104-01,,Flow Cytometric Evaluation of Biomarkers,"STETLER-STEVENSON, MARYALICE",NIH,,"$367,503"
Lymphoma,2008,NCI,1Z01BC011135-01,,Molecular Mechanism of Lymphomagenesis,"RAFFELD, MARK",NIH,,"$203,233"
Lymphoma,2008,NCI,1Z01CP004410-32,,Family Studies,"TUCKER, MARGARET",NIH,,"$7,530,091"
Lymphoma,2008,NCI,1Z01CP005782-14,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$1,060,598"
Lymphoma,2008,NCI,1Z01CP005803-14,,Genetic Epidemiology,"GOLDSTEIN, ALISA",NIH,,"$513,753"
Lymphoma,2008,NCI,1Z01CP010125-13,,Cancer Risk and Environmental Exposures,"CANTOR, KENNETH",NIH,,"$106,318"
Lymphoma,2008,NCI,1Z01CP010127-13,,Etiologic Studies of Diet and Cancer,"SCHATZKIN, ARTHUR",NIH,,"$15,880"
Lymphoma,2008,NCI,1Z01CP010131-13,,Studies of Medical Radiation and Other Therapeutic Agents,"RON, ELAINE",NIH,,"$4,866,860"
Lymphoma,2008,NCI,1Z01CP010150-09,,"Infections, immunity, and inflammation in cancer","ENGELS, ERIC",NIH,,"$2,118,458"
Lymphoma,2008,NCI,1Z01CP010153-09,,"Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and IndustrialCh","WARD, MARY",NIH,,"$1,515,624"
Lymphoma,2008,NCI,1Z01CP010170-08,,Multidisciplinary Studies of Lymphoma,"HARTGE, PATRICIA",NIH,,"$1,222,206"
Lymphoma,2008,NCI,1Z01CP010176-08,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$5,833,949"
Lymphoma,2008,NCI,1Z01CP010183-06,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$1,551,349"
Lymphoma,2008,NCI,1Z01CP010200-01,,Genome-Wide Association Studies,"FRAUMENI, JOSEPH",NIH,,"$50,039"
Lymphoma,2008,NIDDK,1Z01DK060001-14,,Nuclear Trafficking of HIV Regulatory Proteins,"HANOVER, JOHN",NIH,,"$361,084"
Lymphoma,2008,NIEHS,1Z01ES101965-04,,Eukaryotic Transcriptional Regulation,"WADE, PAUL",NIH,,"$1,658,625"
Lymphoma,2008,NIEHS,1Z01ES102265-02,,Methods and Applications for Population-based Incidence and Mortality Statistics,"DINSE, GREGG",NIH,,"$120,375"
Lymphoma,2008,NEI,1Z01EY000222-23,,Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases,"CHAN, CHI-CHAO",NIH,,"$1,317,817"
Lymphoma,2008,NEI,1Z01EY000356-08,,Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis),"NUSSENBLATT, ROBERT",NIH,,"$375,507"
Lymphoma,2008,NEI,1Z01EY000375-08,,Primary Intraocular Lymphoma and Animal Models,"NUSSENBLATT, ROBERT",NIH,,"$155,871"
Lymphoma,2008,NHLBI,1Z01HL005076-03,,Molecular Effects of Bortezomib in Mantle Cell Lymphoma,"WIESTNER, ADRIAN",NIH,,"$657,663"
Lymphoma,2008,NCI,1Z01SC000550-28,,Lymphoma Disease Discovery and Defintion,"JAFFE, ELAINE",NIH,,"$736,790"
Lymphoma,2008,NCI,1Z01SC003669-19,,Regulation of Cutaneous Accessory Cell Activity in Health and Disease,"UDEY, MARK",NIH,,"$411,997"
Lymphoma,2008,NCI,1Z01SC004002-39,,IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"WALDMANN, THOMAS",NIH,,"$1,990,761"
Lymphoma,2008,NCI,1Z01SC006741-15,,Lymphoma Studies,"WILSON, WYNDHAM",NIH,,"$337,660"
Lymphoma,2008,NCI,1Z01SC010353-09,,Experimental Therapeutics of Pediatric Hematopoietic Malignancies,"WAYNE, ALAN",NIH,,"$1,135,420"
Lymphoma,2008,NCI,1Z01SC010356-09,,A Role for KSHV in the Pathogenesis of Malignancies,"TOSATO, GIOVANNA",NIH,,"$487,029"
Lymphoma,2008,NCI,1Z01SC010357-09,,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"ZHENG, ZHI-MING",NIH,,"$1,003,067"
